Randomized phase III trial of the Southern Italy Oncology Group comparing sequential ifosfamide + gemcitabine followed by cisplatin + navelbine (IG -> PN) versus the opposite sequence (PN -> IG) versus cisplatin + navelbine (PN) versus gemcitabine + cisplatin (GP) in stage III–IV non small cell lung cancer (NSCLC)

V Gebbia; D Galetta; M Caruso; N Borsellino; F Varvara; M Tirrito; A Testa; R Valenza; G Pandolfo; M Loizzi; E Durini; G Pezzella; F Sollitto; M Rinaldi; B Agostara; G Colucci

doi:10.1016/s0169-5002(00)80084-7

Randomized phase III trial of the Southern Italy Oncology Group comparing sequential ifosfamide + gemcitabine followed by cisplatin + navelbine (IG -> PN) versus the opposite sequence (PN -> IG) versus cisplatin + navelbine (PN) versus gemcitabine + cisplatin (GP) in stage III–IV non small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(00)80084-7 ◽

2000 ◽

Vol 29 (1) ◽

pp. 27

Author(s):

V Gebbia ◽

D Galetta ◽

M Caruso ◽

N Borsellino ◽

F Varvara ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Southern Italy ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Opposite Sequence

Download Full-text

A randomized phase III trial of the Southern Italy Oncology Group (G.O.I.M.). of mitomycin C plus vindesine and cisplatin (MVP regimen) versus vinorelbine plus cisplatin (PV regimen) in stage III–IV non small cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(00)80063-x ◽

2000 ◽

Vol 29 (1) ◽

pp. 21 ◽

Cited By ~ 1

Author(s):

D Galetta ◽

V Gebbia ◽

F Riccardi ◽

N Borsellino ◽

C Gridelli ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Mitomycin C ◽

Cell Lung Cancer ◽

Southern Italy ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

87 Randomized phase III trial of mitomycin plus vindesine and cisplatin versus vinorelbine and cisplatin in stage III–IV non-small cell lung cancer: A Southern Italy Oncology Group study (G.O.I.M.)

Lung Cancer ◽

10.1016/s0169-5002(97)89366-x ◽

1997 ◽

Vol 18 ◽

pp. 25

Author(s):

V. Gebbia ◽

D. Galeta ◽

F. Riccardi ◽

C. Gridelli ◽

A. Testa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Southern Italy ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial

Lung Cancer ◽

10.1016/s0169-5002(00)80258-5 ◽

2000 ◽

Vol 29 (1) ◽

pp. 79 ◽

Cited By ~ 1

Author(s):

P Comella ◽

G Frasci ◽

N Panza ◽

G Nicolella ◽

L Manzione ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Southern Italy ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Stage Analysis

Download Full-text

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2017.05.037 ◽

2017 ◽

Vol 83 ◽

pp. 302-312 ◽

Cited By ~ 8

Author(s):

David Ferry ◽

Lucinda Billingham ◽

Hugh Jarrett ◽

David Dunlop ◽

Penella J. Woll ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC) - final results of a British Thoracic Oncology Group (BTOG) trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7066 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7066-7066

Author(s):

P. Lorigan ◽

R. Booton ◽

L. Ashcroft ◽

K. O'Byrne ◽

H. Anderson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

A British Thoracic Oncology Group phase III trial of Gemcitabine plus Cisplatin at 80 mg/m^2 versus Gemcitabine plus Cisplatin at 50 mg/m^2 versus Gemcitabine plus Carboplatin area under the concentration-time curve (AUC) 6 in stage IIIB/IV non-small cell lung cancer (NSCLC)

http://isrctn.org/> ◽

10.1186/isrctn80153848 ◽

2012 ◽

Author(s):

David Ferry

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Time Curve ◽

Phase Iii Trial ◽

Concentration Time

Download Full-text

O-095 A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small cell lung cancer — A randomised multicentre trial of the British thoracic oncology group (BTOG1)

Lung Cancer ◽

10.1016/s0169-5002(05)80229-6 ◽

2005 ◽

Vol 49 ◽

pp. S34

Author(s):

P. Lorigan

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Mitomycin C ◽

Cell Lung Cancer ◽

Multicentre Trial ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)

Annals of Oncology ◽

10.1093/annonc/mdl396 ◽

2007 ◽

Vol 18 (2) ◽

pp. 324-330 ◽

Cited By ~ 35

Author(s):

P. Comella ◽

G. Filippelli ◽

G. De Cataldis ◽

B. Massidda ◽

G. Frasci ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Southern Italy ◽

Randomised Trial ◽

Locally Advanced ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung

Download Full-text

A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)

Annals of Oncology ◽

10.1093/annonc/mdl078 ◽

2006 ◽

Vol 17 (7) ◽

pp. 1111-1119 ◽

Cited By ~ 44

Author(s):

R. Booton ◽

P. Lorigan ◽

H. Anderson ◽

S. Baka ◽

L. Ashcroft ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Mitomycin C ◽

Cell Lung Cancer ◽

Multicentre Trial ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Phase III Trial of Paclitaxel Plus Carboplatin With or Without Tirapazamine in Advanced Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S0003

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70418-4 ◽

2007 ◽

Vol 2007 ◽

pp. 200-203

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Southwest Oncology Group ◽

Group Trial

Download Full-text